A prospective Study of Continuous ECG Monitoring with Wearable Wireless Patch-Based Solution -Vigo Heart Compared with a Conventional Ambulatory ECG Holter - VC-VHT

Vigocare Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年8月21日

试验速览

暂无简介。

•Age more than 18 years of both the genders, Patient capable of giving informed consent, able to comply with long term continuous monitoring with Vigo Heart patch and Holter,Suspected arrhythmia related signs, palpitations of uncertain etiology, pre syncope of uncertain etiology, patient at risk of arrhythmia after myocardial infraction, cognitive cardiac failure or valvular heart disease

•Age less than 128 years, have known skin allergies to adhesive and psoriasis, patients with any dermatitis or infected skin or skin with burns on chest area, asternal or thoracic incision that extends under the patch within 3 months from the date of enrollments, patient with chest injuries, intra cerebral bleed in medical history,end stage renal disease, pregnant and lactating women, infective endo condition, anticipated to be exposed to high frequency equipment MRI and CT-Scans, Stroke induced by trauma, infection surgery procedures, Dementia, mental disorders, suspected non-compliance of the study, enrolled patients with connectivity issues, lead off, data loss or analyzable data <60%

发起方

Vigocare Pvt Ltd